Insiders · Profile

Feder Julie B

Chief Financial Officer at Aura Biosciences. Filing since 31 Oct 2022. CIK 0001710237

Company
Date
Role
Action
Shares
Amount
Of holding
18 Oct 2024
Chief Financial Officer
Sold on a plan
25,131
$302.36K
15.8%
23 Jan 2024
Chief Financial Officer
Sold at will
6,609
$50.52K
9.5%
6 Nov 2023
Chief Financial Officer
Sold on a plan
3,900
$47.05K
5.3%
30 Oct 2023
Chief Financial Officer
Sold at will
3,385
$23.09K
4.6%
31 Oct 2022
Chief Financial Officer
Sold, plan not stated
2,015
$25.09K
7.7%
5 decisions on file.